Potent adjuvantic activity of a CCR1-agonistic bis-quinoline
Authors:
Open Access
- 1 January 2012
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 22 (1) , 293-295
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Evaluation of the Safety and Immunogenicity in Rhesus Monkeys of a Recombinant Malaria Vaccine for Plasmodium vivax with a Synthetic Toll-Like Receptor 4 Agonist Formulated in an EmulsionInfection and Immunity, 2011
- The safety evaluation of adjuvants during vaccine development: The AS04 experienceVaccine, 2011
- Toward self-adjuvanting subunit vaccines: Model peptide and protein antigens incorporating covalently bound toll-like receptor-7 agonistic imidazoquinolinesBioorganic & Medicinal Chemistry Letters, 2011
- Preliminary evaluation of a 3H imidazoquinoline library as dual TLR7/TLR8 antagonistsBioorganic & Medicinal Chemistry, 2011
- The Structural Biology of Toll-like ReceptorsStructure, 2011
- Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine AdjuvantPLOS ONE, 2011
- Syntheses of fluorescent imidazoquinoline conjugates as probes of Toll-like receptor 7Bioorganic & Medicinal Chemistry Letters, 2010
- Phosphorothioate 2′ Deoxyribose Oligomers as Microbicides That Inhibit Human Immunodeficiency Virus Type 1 (HIV-1) Infection and Block Toll-Like Receptor 7 (TLR7) and TLR9 Triggering by HIV-1Antimicrobial Agents and Chemotherapy, 2010
- Structure−Activity Relationships in Human Toll-Like Receptor 7-Active Imidazoquinoline AnaloguesJournal of Medicinal Chemistry, 2010
- Structure−Activity Relationships in Toll-like Receptor-2 Agonistic Diacylthioglycerol LipopeptidesJournal of Medicinal Chemistry, 2010